Winstrol 50 mg 50 Tablets Saxon Pharma USA
$99.00
Product Short Description
Winstrol 50 mg 50 Tablets Saxon Pharma USA delivers stanozolol (C21H32N2O), the pyrazole-ring fused DHT anabolic steroid exhibiting extreme anabolic potency (~320:30 ratio), at premium oral 50 mg strength matching institutional performance specifications. Domestic production serves DEA Schedule III compliant channels exclusively.
Product Overview
Saxon Pharma USA’s Winstrol 50 mg presents stanozolol, featuring C2-C3 pyrazole substitution preventing aromatization characteristic of 17α-methylated DHT derivatives (~8-hour half-life), in USP-equivalent scored tablets for institutional catalogs. The 50-tablet tamper-evident configuration supports CIII-compliant inventory management across encrypted specialist platforms requiring batch traceability essential for DEA-regulated workflows.
U.S. domestic manufacturing eliminates customs exposure distinguishing legitimate Schedule III supply from underground tablet presses prevalent in non-verified markets. High-dosage format serves advanced resellers managing controlled substance inventories rather than prescription crossover (discontinued 2 mg Winstrol).
Winstrol targets verified CIII ecosystems emphasizing commercial positioning without protocols or claims.
Brand & Manufacturer Information
Saxon Pharma USA produces Schedule III anabolics through domestic facilities serving institutional performance distribution requiring controlled substance compliance. Winstrol 50 mg maintains catalog continuity alongside Saxon Anavar authenticating legitimate institutional supply versus powder-converted alternatives.
Domestic warehousing supports DEA Form 222 record-keeping confirming stanozolol identity/potency across encrypted platforms.
Active Compound Information
Contains stanozolol (17α-methyl-2’H-5α-androst-2-enopyrazol-17β-ol), heterocyclic DHT derivative enabling high anabolic:androgenic dissociation with no estrogen conversion and moderate hepatotoxicity profile characteristic of 17α-methylated oral steroids. DEA Schedule III (21 CFR 1308.13) reflects performance dosage escalation.
50 mg strength represents institutional-grade escalation from discontinued prescription formats. WADA S1a prohibited globally.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Winstrol 50 mg 50 Tablets Saxon Pharma USA |
| Active Compound | Stanozolol (C21H32N2O) |
| Strength | 50 mg per scored tablet |
| Quantity | 50 tablets per bottle |
| Form | Oral scored tablets |
| Category | DEA Schedule III controlled substance |
| Packaging | Tamper-evident HDPE bottle |
| Label Elements | 50 mg declaration, batch code, CIII warnings |
Quality Control & Testing Standards
50 mg stanozolol mandates USP potency assay (90-110% HPLC), dissolution (Q=80% 30 min), and uniformity verification. Saxon batch documentation confirms C21H32N2O identity distinguishing legitimate production from underground alternatives prone to under-dosing.
50-tablet institutional bottling prevents diversion matching DEA protocols.
Intended Use & Market Positioning
Serves CIII-licensed institutional researchers managing high-dosage DEA Schedule III inventories exclusively. 50 mg/50-tab excludes crossover within premium domestic catalogs. No protocols represented.
Legal & Regulatory Disclaimer
Stanozolol constitutes DEA Schedule III under 21 USC §812; non-medical handling violates Controlled Substances Act (5 years/$250,000 penalties). Buyer assumes Form 222 compliance; zero medical claims provided.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.